/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
A study to assess the ability of the HFA-ICOS risk stratification tool to predict cancer therapy-related cardiac dysfunction for patients receiving anthracycline chemotherapy.
Event: ESC Congress 2024
Topic: Cardio-Oncology
Session: Cardiovascular complications in cardio-oncology: risk assessment
OCT versus angiography for post insertion assessment of everolimus-eluting bioresorbale vascular scaffolds and the prevention of major adverse cardiovascular events.
Event: ESC Congress 2016
Topic: PCI / stents: devices and technique
Session: Technical aspects of bioresorbable scaffold-based PCI
